Rolando Sanchez Sanchez, MD
Pulmonary Disease · Iowa City, IANPI 1043455215
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.6%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Pinnacle Biologics, Inc at 51.2% of the total. Reporting peaked in 2022 at $5,320 and has fallen 92.8% since, to $381 in 2025.
Across 65 payments — averaging $185.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle Biologics, Inc$6K
- Intuitive Surgical$4K
- Johnson & Johnson$1K
- Amgen$337
- Olympus America Inc.$109
- Covidien LP$37
- plus $44 from 2 others
What the payments were for
- Speaking & faculty fees$2,50021%
- Travel & lodging$5,99350%
- Food & beverage$3,55429%
- Education$260%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle Biologics, Inc | 22 | $6,186 |
| Intuitive Surgical | 31 | $4,123 |
| Johnson & Johnson | 5 | $1,245 |
| Amgen | 3 | $337 |
| Olympus America Inc. | 1 | $109 |
| Covidien LP | 1 | $37 |
| Merck | 1 | $26 |
| Puma Biotechnology, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Photofrin$5,311
- Da Vinci Surgical System$3,269
- MONARCH$1,216
- Tavneos$249
How this compares
$12,081 in reported general payments places this provider in the 85th percentile of 110 pulmonary disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 70 | $36,826 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $11,041 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,035 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,240 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,137 |
| Azithromycin | 92 | $535 |
| Ethambutol Hcl | 12 | $409 |
| Rifampin | 11 | $270 |
| Gabapentin | 11 | $180 |
| Prednisone | 12 | $50 |
| Furosemide | 12 | $46 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Iowa City
- Alejandro ComellasIowa City$54K
- Nabeel HamzehIowa City$9K
- Douglas HornickIowa City$8K
- Robert SmythIowa City$6K
- Joel KlineIowa City$5K
- Tahuanty PenaIowa City$2K
- Alan MoyIowa City$2K
- Kimberly Baker-El AbiadIowa City$831
- Bryan KrajicekCouncil Bluffs$470K
- Sumit MukherjeeCouncil Bluffs$264K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.